Results
Haemonetics Corporation
07/25/2024 | Press release | Distributed by Public on 07/25/2024 14:11
Submission of Matters to a Vote of Security Holders Form 8 K
Item 5.07 Submission of Matters to a Vote of Security Holders.
The Company's 2024 Annual Meeting of Shareholders was held on Thursday, July 25, 2024. Of the 50,953,098 shares outstanding and entitled to vote at the meeting, 48,912,250 shares were represented at the meeting, constituting a quorum of 95.99%.
The results of the votes for each proposal considered at the meeting are set forth below:
1. The shareholders elected each of Christopher A. Simon, Robert E. Abernathy, Diane M. Bryant, Michael J. Coyle, Charles J. Dockendorff, Lloyd E. Johnson, Mark W. Kroll, Claire Pomeroy and Ellen M. Zane as directors for one-year terms expiring in 2025 based upon the following votes:
| Nominees | For | Withhold | Broker Non-Votes |
| Christopher A. Simon | 47,563,311 | 269,386 | 1,079,553 |
| Robert E. Abernathy | 47,233,098 | 599,599 | 1,079,553 |
| Diane M. Bryant | 47,637,507 | 195,190 | 1,079,553 |
| Michael J. Coyle | 47,492,931 | 339,766 | 1,079,553 |
| Charles J. Dockendorff | 46,789,643 | 1,043,054 | 1,079,553 |
| Lloyd E. Johnson | 47,243,880 | 588,817 | 1,079,553 |
| Mark W. Kroll | 46,938,807 | 893,890 | 1,079,553 |
| Claire Pomeroy | 47,553,094 | 279,603 | 1,079,553 |
| Ellen M. Zane | 47,122,780 | 709,917 | 1,079,553 |
2. The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:
| For | Against | Abstain | Broker Non-Votes |
| 46,230,466 | 1,460,004 | 142,227 | 1,079,553 |
3. The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes:
| For | Against | Abstain |
| 47,738,769 | 1,049,682 | 123,799 |